echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Jun Shengtai will present the htd1801 study data at the 2019 annual meeting of the American Association for the Study of Hepatology

    Jun Shengtai will present the htd1801 study data at the 2019 annual meeting of the American Association for the Study of Hepatology

    • Last Update: 2021-02-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Junsantai announced that several preclinical studies of the company's innovative HTD1801 will be presented in oral reports and wall reports at the 70th Annual Meeting of the American Association for the Study of Hepatology (AASLD) in 2019, in Boston, USA, November 8-12.
    The Liver Meeting is the world's largest and most authoritative liver disease conference, with nearly 10,000 liver disease professionals from around the world attending each year to share breakthrough research findings, new treatment guidelines and the latest treatment advances in the field of hepatology.
    Developed by the Junsantai team, HTD1801 is conducting Phase II clinical trials in the United States for non-alcoholic fatty hepatitis (NASH) and primary sclerotic bileitis (PSC). HTD1801 has obtained FDA fast-track eligibility and PSC orphan drug certification for both adaptations. Phase II clinical data are expected to be released in 2020. (Medical Rubik's Cube)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.